Baker McKenzie has successfully advised Uniphar plc on its acquisition of the Orspec Group

Baker McKenzie has advised Uniphar plc on its acquisition of the Orspec Group.

Uniphar is a diversified healthcare services business based in Ireland, servicing the requirements of multinational pharmaceutical and medical technology manufacturers. In 2021, Uniphar generated revenue of EUR 1.9 billion. With a workforce of more than 2,900, the Group is active in Europe and the US.

Uniphar said it had recently marked its entry into the Asia-Pacific market after completing the acquisition of Australia-headquartered Orspec Pharma. The company, which also has hubs in Singapore and New Zealand, “specializes in the supply of unlicensed medicines and the delivery of expanded access programs across the region”, Uniphar said. Uniphar group chief executive Ger Rabbette said the acquisition “will support our goal of becoming a global leader in product access services”.

The Baker McKenzie team was led by Ben McLaughlin with assistance from Ciarán O'Brien, Jamie Sung, Amy Middlebrook, Dao Yi Lim, Alex Hewitt, Taylor Zhao, Brett Walker and Jo Grange.

McLaughlin commented: "We are delighted to assist our client Uniphar on their expansion into Australia and Asia-Pacific. "